AU7052291A - Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus - Google Patents
Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virusInfo
- Publication number
- AU7052291A AU7052291A AU70522/91A AU7052291A AU7052291A AU 7052291 A AU7052291 A AU 7052291A AU 70522/91 A AU70522/91 A AU 70522/91A AU 7052291 A AU7052291 A AU 7052291A AU 7052291 A AU7052291 A AU 7052291A
- Authority
- AU
- Australia
- Prior art keywords
- virus
- provirus
- against infection
- derived
- animals against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000700605 Viruses Species 0.000 title 2
- 241000714266 Bovine leukemia virus Species 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8916929A FR2655855B1 (en) | 1989-12-20 | 1989-12-20 | GENETIC PROTECTION OF ANIMALS AGAINST INFECTION WITH THE BOVINE LEUCEMOGEN VIRUS, AND PROVIRUS AND RECOMBINANT VIRUS DERIVED FROM THIS VIRUS. |
FR8916929 | 1989-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7052291A true AU7052291A (en) | 1991-07-18 |
Family
ID=9388777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU70522/91A Abandoned AU7052291A (en) | 1989-12-20 | 1990-12-20 | Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7052291A (en) |
FR (1) | FR2655855B1 (en) |
WO (1) | WO1991009116A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9520641D0 (en) * | 1995-10-10 | 1995-12-13 | Medical Res Council | Improvements in or relating to protection against intracellular infection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2606030B1 (en) * | 1986-10-31 | 1989-10-20 | Pasteur Institut | DEFECTIVE RECOMBINANT RETROVIRUSES, MANUFACTURING METHOD THEREOF AND APPLICATIONS THEREOF, PARTICULARLY FOR STUDYING THE INTERACTION OF WILD RETROVIRUSES WITH CELL LINES INFECTIBLE THEREWITH |
JPH02502425A (en) * | 1987-03-09 | 1990-08-09 | ジ・アップジョン・カンパニー | Transgenic animal cells resistant to viral infection |
WO1989005349A1 (en) * | 1987-12-09 | 1989-06-15 | The Australian National University | Method of combating viral infections |
JPH03504079A (en) * | 1988-03-21 | 1991-09-12 | カイロン コーポレイション | recombinant retrovirus |
-
1989
- 1989-12-20 FR FR8916929A patent/FR2655855B1/en not_active Expired - Lifetime
-
1990
- 1990-12-20 AU AU70522/91A patent/AU7052291A/en not_active Abandoned
- 1990-12-20 WO PCT/FR1990/000935 patent/WO1991009116A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2655855B1 (en) | 1992-04-10 |
FR2655855A1 (en) | 1991-06-21 |
WO1991009116A1 (en) | 1991-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1628895A (en) | Recombinant virus | |
AU7246687A (en) | 5-arylalkyl-4-alkoxy-2(5H)-furanones, intermediates and processes for the preparation thereof and medicaments containing them | |
AU2445888A (en) | Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus | |
AU9156291A (en) | Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs | |
AU4653989A (en) | Biologically competent, virus inactivated albumin | |
ATA902590A (en) | RECOMBINANT SMALL VIRUS | |
AU3636189A (en) | Hiv-2 virus variants | |
AU625328B2 (en) | Recombinant varicella-zoster glycoproteins and their derivatives | |
AU1632392A (en) | Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus | |
EP0584558A3 (en) | A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein. | |
CA2185541A1 (en) | Cytotoxic t-cell epitopes | |
AU570328B2 (en) | Solid medicament formulations containing dihydropyridines | |
OA09427A (en) | "Viral treatment system". | |
EP0525828A3 (en) | Recombinant polypeptides and their uses, including assay for aids virus | |
AU3961793A (en) | Virus resistant plants | |
AU7691191A (en) | Recombinant spider silk proteins through genetic engineering | |
WO1990013281A3 (en) | Method of suppressing hiv infection | |
AU2520692A (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus | |
AU7052291A (en) | Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus | |
IL106591A0 (en) | An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it | |
AU5836390A (en) | Human lymphoma-associated virus | |
CA2141951A1 (en) | Inhibition of retrovirus infection | |
AU8976691A (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
AU2542888A (en) | Low molecular weight xylanase glycoprotein | |
EP0244427A4 (en) | Recombinant virus. |